Targeted receptor trafficking affects the efficiency of retrovirus transduction

Biotechnology Progress

Volumn 21, Issue 1, 2005, Pages 263-273

  Krishna, Delfi ^a   Raykin, Julia ^b   Le Doux, Joseph M ^c  

^a Georgia Institute of Technology   (United States)

^b SOUTHERN POLYTECHNIC STATE UNIVERSITY   (United States)

^c Emory University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; PROTEINS; VIRUSES;

BINDING SITES; CELLULAR RECEPTORS; EXTRACELLULAR DOMAINS; RETROVIRUS TRANSDUCTION;

BIOTECHNOLOGY;

INTERLEUKIN 2 RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; GENE TRANSFER; GENETIC TRANSDUCTION; GENETICS; HELA CELL; HUMAN; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN TRANSPORT; RETROVIRUS; TUMOR CELL LINE;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CELLS, CULTURED; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT; RECEPTORS, INTERLEUKIN-2; RETROVIRIDAE; TRANSDUCTION, GENETIC;

MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 13644251825     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp049767b     Document Type: Article

References (49)

1. Barrette, S.; Orlic, D. Alternative Viral Envelopes for Oncoretroviruses to Increase Gene Transfer into Hematopoietic Stem Cells. Curr. Opin. Mol. Ther. 2000, 2, 507-514.
2. Mulligan, R. C. The Basic Science of Gene Therapy. Science 1993, 260, 926-932.
3. Robbins, P. D.; Tahara, H.; Ghivizzani, S. C. Viral Vectors for Gene Therapy. Trends Biotechnol. 1998, 16, 35-40.
4. Battini, J.-L.; Danos, O.; Heard, J. M. Receptor-Binding Domain of Murine Leukemia Virus Envelope Glycoproteins. J. Virol. 1995, 69, 713-719.
5. Marin, M. et al. Targeted Infection of Human Cells Via Major Histocompatibility Complex Class I Molecules by Moloney Murine Leukemia Virus-Derived Viruses Displaying Single-Chain Antibody Fragment-Envelope Fusion Proteins. J. Virol. 1996, 70, 2957-2962.
6. Martin, F. et al. Retrovirus Targeting by Tropism Restriction to Melanoma Cells. J. Virol. 1999, 73, 6923-6929.
7. Retroviral Vector Targeting to Melanoma Cells by Single-Chain Antibody Incorporation in Envelope. Hum. Gene Ther. 1998, 9, 737-746.
8. Yajima, T. et al. Retroviral Vector Targeting Human Cells Via C-Kit-Stem Cell Factor Interaction. Hum. Gene Ther. 1998, 9, 779-787.
9. Kasahara, N. et al. Tissue-Specific Targeting of Retroviral Vectors through Ligand-Receptor Interactions. Science 1994, 266, 1373-1376.
10. Schnierle, B. S. et al. Expression of Chimeric Envelope Proteins in Helper Cell Lines and Integration into Moloney Murine Leukemia Virus Particles. Gene Ther. 1996, 3, 334-342.
11. Maurice, M. et al. Efficient Gene Transfer into Human Primary Blood Lymphocytes by Surface-Engineered Lentiviral Vectors That Display a T Cell-Activating Polypeptide. Blood 2002, 99, 2342-2350.
12. Verhoeyen, E. et al. 11-7 Surface-Engineered Lentiviral Vectors Promote Survival and Efficient Gene Transfer in Resting Primary T Lymphocytes. Blood 2003, 101, 2167-2174. Epub 2002 Nov 2121.
13. Gordon, E. M. et al. Lesion-Targeted Injectable Vectors for Vascular Restenosis. Hum. Gene Ther. 2001, 12, 1277-1287.
14. Narayan, S. et al. Two Retroviral Entry Pathways Distinguished by Lipid Raft Association of the Viral Receptor and Differences in Viral Infectivity. J. Virol. 2003, 77, 1977-1983.
15. Kizhatil, K.; Albritton, L. M. Requirements for Different Components of the Host Cell Cytoskeleton Distinguish Ecotropic Murine Leukemia Virus Entry Via Endocytosis from Entry Via Surface Fusion. J. Virol. 1997, 71, 7145-7156.
16. Etienne-Julan, M. et al. The Efficiency of Cell Targeting by Recombinant Retroviruses Depends on the Nature of the Receptor and the Composition of the Artificial Cell-Virus Linker. J. Gen. Virol. 1992, 73, 3251-3255.
17. Goud, B. et al. Antibody-Mediated Binding of a Murine Ecotropic Moloney Retroviral Vector to Human Cells Allows Internalization but Not the Establishment of the Proviral State. Virology 1988, 163, 251-254.
18. Naslavsky, N. et al. Convergence of Non-Clathrin- and Clathrin-Derived Endosomes Involves Arf6 Inactivation and Changes in Phosphoinositides. Mol. Biol. Cell 2003, 14, 417-431.
19. Radhakrishna, H.; Donaldson, J. G. Adp-Ribosylation Factor 6 Regulates a Novel Plasma Membrane Recycling Pathway. J. Cell. Biol. 1997, 139, 49-61.
20. Hemar, A.; Dautry-Varsat, A. Cyclosporin a Inhibits the Interleukin 2 Receptor Alpha Chain Gene Transcription but Not Its Cell Surface Expression: The Alpha Chain Stability Can Explain This Discrepancy. Eur. J. Immunol. 1990, 20, 2629-2635.
21. Delahunty, M. D. et al. Uncleaved Signals for Glycosylphosphatidylinositol Anchoring Cause Retention of Precursor Proteins in the Endoplasmic Reticulum. J. Biol. Chem. 1993, 268, 12017-12027.
22. Letourneur, F.; Klausner, R. D. A Novel Di-Leucine Motif and a Tyrosine-Based Motif Independently Mediate Lysosomal Targeting and Endocytosis of Cd3 Chains. Cell 1992, 69, 1143-1157.
23. Nakanishi, K. et al. Role and Regulation of Interleukin (Il)-2 Receptor Alpha and Beta Chains in Il-2-Driven B-Cell Growth. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 3551-3555.
24. John, S. et al. Regulation of Cell-Type-Specific Interleukin-2 Receptor Alpha-Chain Gene Expression: Potential Role of Physical Interactions between Elf-1, Hmg-I(Y), and Nf-Kappa B Family Proteins. Mo.l Cell. Biol. 1995, 15, 1786-1796.
25. Doucette, M. M.; Stevens, V. L. Folate Receptor Function Is Regulated in Response to Different Cellular Growth Rates in Cultured Mammalian Cells. J. Nutr. 2001, 131, 2819-2825.
26. Takebe, Y. et al. Sr Alpha Promoter: An Efficient and Versatile Mammalian Cdna Expression System Composed of the Simian Virus 40 Early Promoter and the R-U5 Segment of Human T-Cell Leukemia Virus Type 1 Long Terminal Repeat. Mol. Cell. Biol. 1988, 8, 466-472.
27. McDonald, D. et al. Visualization of the Intracellular Behavior of Hiv in Living Cells. J. Cell. Biol. 2002, 159, 441-452. Epub 2002 Nov 2004.
28. Cosset, F. L. et al. High-Titer Packaging Cells Producing Recombinant Retroviruses Resistant to Human Serum. J. Virol. 1995, 69, 7430-7436.
29. Struhl, K. S.; J. A.; Seidman, J. G.; Moore, D. D.; Kingston, R. E.; Brent, R.; Ausubel, F. M. Short Protocols in Molecular Biology; John Wiley & Sons Inc.: New York, 1999.
30. Smith, R. F. Microscopy and Photomicrography; CRC Press: Boca Raton, 1994.
31. Volpicelli, L. A. et al. Rab5-Dependent Trafficking of the M4 Muscarinic Acetylcholine Receptor to the Plasma Membrane, Early Endosomes, and Multivesicular Bodies. J. Biol. Chem. 2001, 276, 47590-47598. Epub 2001 Oct 47594.
32. Le Doux, J. M. et al. Complexation of Retrovirus with Cationic and Anionic Polymers Increases the Efficiency of Gene Transfer. Hum. Gene Ther. 2001, 12, 1611-1621.
33. Yang, X. Y. et al. Development of a Quantitative Antigen-Specific Cell-Based Elisa for the 7g7/B6 Monoclonal Antibody Directed toward Il-2ralpha. J. Immunol. Methods 2003, 277, 87-100.
34. Shinnick, T. M. et al. Nucleotide Sequence of Moloney Murine Leukaemia Virus. Nature 1981, 293, 543-548.
35. Kobayashi, H. et al. Similarities in the Biodistribution of Iodine-Labeled Anti-Tac Single-Chain Disulfide-Stabilized Fv Fragment and Anti-Tac Disulfide-Stabilized Fv Fragment. Nucl. Med. Biol. 1998, 25, 387-393.
36. Niwa, H. et al. Efficient Selection for High-Expression Transfectants with a Novel Eukaryotic Vector. Gene 1991, 108, 193-199.
37. Morgan, J. R. et al. Rapid Quantitation of Recombinant Retroviruses. Biotechnol. Prog. 1994, 10, 441-446.
38. Morgan, J. R. et al. Retrovirus Infection: Effect of Time and Target Cell Number. J. Virol. 1995, 69, 6994-7000.
39. Tardif, M. R.; Tremblay, M. J. Presence of Host Icam-1 in Human Immunodeficiency Virus Type 1 Virions Increases Productive Infection of Cd4+ T Lymphocytes by Favoring Cytosolic Delivery of Viral Material. J. Virol. 2003, 77, 12299-12309.
40. Rodrigues, P.; Heard, J. M. Modulation of Phosphate Uptake and Amphotropic Murine Leukemia Virus Entry by Posttranslational Modifications of Pit-2. J. Virol. 1999, 73, 3789-3799.
41. Orlic, D. et al. Transduction Efficiency of Cell Lines and Hematopoietic Stem Cells Correlates with Retrovirus Receptor mRNA Levels. Stem Cells 1997, 1, 23-28.
42. Siess, D. C. et al. Exceptional Fusogenicity of Chinese Hamster Ovary Cells with Murine Retroviruses Suggests Roles for Cellular Factor(s) and Receptor Clusters in the Membrane Fusion Process. J. Virol. 1996, 70, 3432-3439.
43. Kurre, P. et al. Efficient Transduction by an Amphotropic Retrovirus Vector Is Dependent on High-Level Expression of the Cell Surface Virus Receptor. J. Virol. 1999, 73, 495-500.
44. Guinea, R.; Carrasco, L. Requirement for Vacuolar Proton-ATPase Activity During Entry of Influenza Virus into Cells. J. Virol. 1995, 69, 2306-2312.
45. Fredericksen, B. L. et al. Inhibition of Endosomal/Lysosomal Degradation Increases the Infectivity of Human Immunodeficiency Virus. J. Virol. 2002, 76, 11440-11446.
46. Schaeffer, E. et al. Human Immunodeficiency Virus Type 1 Nef Functions at the Level of Virus Entry by Enhancing Cytoplasmic Delivery of Virions. J. Virol. 2001, 75, 2993-3000.
47. Marechal, V. et al. Cytosolic Gag P24 as an Index of Productive Entry of Human Immunodeficiency Virus Type 1. J. Virol. 1998, 72, 2208-2212.
48. Manes, S. et al. Membrane Raft Microdomains Mediate Lateral Assemblies Required for HIV-1 Infection. EMBO Rep. 2000, 1, 190-196.
49. Liao, Z. et al. Lipid Rafts and Hiv Pathogenesis: Virion-Associated Cholesterol Is Required for Fusion and Infection of Susceptible Cells. AIDS Res. Hum. Retroviruses 2003, 19, 675-687.